CD274 and non-small cell lung carcinoma: Because high mutation load has been linked with cytolytic activity33,34 and elevated expression of CD274 (PD-L1) is observed in our smoking-related NSCLC patients, the application of immune checkpoint blockade therapies may be expected in the future.